News for Tekla Life Sciences Investors (HQL)

PHILADELPHIA, PA / ACCESSWIRE / October 27, 2023 / Effective close of business today, October 27, 2023, abrdn Inc. (

Tekla Capital Management LLC announced today that the requisite vote has been attained to approve the new investment advisory agreement with abrdn Inc. for each of its four closed-end funds . The...

HQH, HQL, THQ, ...

Dividend-paying CEFs with positive NAV since inception now number only 38, which is less than 10%. Click here for a detailed analysis.

Tekla Life Sciences Investors invests primarily in biotechnology stocks. Read more to see a detailed analysis on HQL.

On September 25, 2023, President Daniel Omstead of Tekla Life Sciences Investors (HQL) made a significant insider purchase, acquiring 10,096 shares of the

On September 20, 2023, President Daniel Omstead of Tekla Life Sciences Investors (HQL) made a significant purchase of 12,000 shares of the company's stock.

The Tekla Healthcare Opportunities Fund's distribution yield appears the most sustainable. Click here to read my most recent analysis of THQ CEF here.

On August 31, 2023, Tekla World Healthcare Fund paid a monthly distribution of $0.1167 per share. It is currently estimated that this distribution is derived from net realized long-term capital gains...

On August 31, 2023, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from net realized short-term...